These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7251157)

  • 1. Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptococcus neoformans-infected mice.
    Fromtling RA; Fromtling AM; Staib F; Müller S
    Infect Immun; 1981 Jun; 32(3):1073-8. PubMed ID: 7251157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response in experimentally induced uremia. V. Description of a model for chronic uremia in the rat that produces a long-term suppressive effect on T cell responses to mitogens.
    Alevy YG; Mueller KR; Hutcheson P; Slavin RG
    J Lab Clin Med; 1983 May; 101(5):717-25. PubMed ID: 6601172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific immunosuppression by Cryptococcus neoformans infection.
    Blackstock R; Hall NK
    Mycopathologia; 1984 Apr; 86(1):35-43. PubMed ID: 6234468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of responses to cryptococcal antigen in murine cryptococcosis.
    Robinson BE; Hall NK; Bulmer GS; Blackstock R
    Mycopathologia; 1982 Dec; 80(3):157-63. PubMed ID: 6219291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia.
    Mezzano S; Pesce AJ; Pollak VE; Michael JG
    Nephron; 1984; 36(1):15-9. PubMed ID: 6606788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.
    Hoag KA; Street NE; Huffnagle GB; Lipscomb MF
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):487-95. PubMed ID: 7546779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1637-44. PubMed ID: 7729867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Infect Immun; 1979 May; 24(2):449-53. PubMed ID: 378854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell response during infection with the MAT a and MAT alpha mating types of Cryptococcus neoformans.
    Rodrigues AR; Heise N; Previato JO; Mendonça-Previato L; Peçanha LM
    Microbes Infect; 2005 Jan; 7(1):118-25. PubMed ID: 15716070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection.
    Lindell DM; Ballinger MN; McDonald RA; Toews GB; Huffnagle GB
    Infect Immun; 2006 Aug; 74(8):4538-48. PubMed ID: 16861640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans.
    Mody CH; Chen GH; Jackson C; Curtis JL; Toews GB
    Mycopathologia; 1994 Jan; 125(1):7-17. PubMed ID: 8028643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.
    Hidore MR; Murphy JW
    Infect Immun; 1986 Feb; 51(2):547-55. PubMed ID: 3510981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemiluminescence and lymphocyte transformation of immune cells in experimental uremia.
    Fromtling RA
    Nephron; 1986; 43(1):78. PubMed ID: 3703075
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral inhibitors of the immune response in uremia. I. Effect of serum and of the supernatant of spleen cultures from uremic rats on the mixed lymphocyte reaction.
    Raskova J; Morrison AB
    Lab Invest; 1978 Jan; 38(1):103-9. PubMed ID: 146111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of mixed lymphocyte culture by uremic adherent spleen cells and peritoneal macrophages is dependent on a cyclophosphamide-sensitive cell.
    Alevy YG; Mueller KR; Slavin RG
    Int Arch Allergy Appl Immunol; 1984; 74(2):97-103. PubMed ID: 6232223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.
    Mody CH; Lipscomb MF; Street NE; Toews GB
    J Immunol; 1990 Feb; 144(4):1472-7. PubMed ID: 1968080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.
    Raskova J; Raska K
    Am J Pathol; 1983 May; 111(2):149-55. PubMed ID: 6221666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1-Th2 cytokine kinetics in the bronchoalveolar lavage fluid of mice infected with Cryptococcus neoformans of different virulences.
    Abe K; Kadota J; Ishimatsu Y; Iwashita T; Tomono K; Kawakami K; Kohno S
    Microbiol Immunol; 2000; 44(10):849-55. PubMed ID: 11128069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.